In vitro transdermal delivery of therapeutic antibodies using maltose microneedles

International Journal of Pharmaceutics

Volumn 368, Issue 1-2, 2009, Pages 109-115

  Li, Guohua ^a   Badkar, Advait ^b   Nema, Sandeep ^b   Kolli, Chandra Sekhar ^a   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

Human IgG; Microneedles; Monoclonal antibody; Transdermal delivery

Indexed keywords

IMMUNOGLOBULIN G; MALTOSE; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; MICRONEEDLE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SECTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, MONOCLONAL; DIFFUSION; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALTOSE; MICROINJECTIONS; NEEDLES; RATS; RATS, HAIRLESS; SKIN; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 58949100880     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.10.008     Document Type: Article

References (23)

1. Amnon C.S., Krymberka I., Danielb D., Hannanb T., Sohnb Z., and Levin G. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Release 89 (2003) 311-320
2. Badkar A.V., Smith A.M., Eppstein J.A., and Banga A.K. Transdermal delivery of interferon alpha-2b using microporation and iontophoresis in hairless rats. Pharm. Res. 24 (2007) 1389-1395
3. Banga A.K. New technologies to allow transdermal delivery of therapeutic proteins and small water-soluble drugs. Am. J. Drug Deliv. 4 (2006) 221-230
4. Banga A.K. Therapeutic Peptides and Proteins: Formulation Processing and Delivery Systems. 2nd ed. (2006), Taylor and Francis
5. Birchall J., Coulman S., Anstey A., Gateley C., Sweetland H., Gershonowitz A., Neville L., and Levin G. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int. J. Pharm. 312 (2006) 15-23
6. Coulman S., Allender C., and Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug Carrier Syst. 23 (2006) 205-258
7. Coulman S.A., Barrow D., Anstey A., Gateley C., Morrissey A., Wilke N., Allender C., Brain K., and Birchall J.C. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr. Drug Deliv. 3 (2006) 65-75
8. Davis S.P., Landis B.J., Adams Z.H., Allen M.G., and Prausnitz M.R. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J. Biomech. 37 (2004) 1155-1163
9. Gill, H.S., 2006. Effect of microneedle design on pain in human subjects. Internet. 11-16-2006.
10. Henry S., McAllister D.V., Allen M.G., and Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87 (1998) 922-925
11. Levin G., Gershonowitz A., Sacks H., Stern M., Sherman A., Rudaev S., Zivin I., and Phillip M. Transdermal delivery of human growth hormone through RF-microchannels. Pharm. Res. 22 (2005) 550-555
12. Lin W., Cormier M., Samiee A., Griffin A., Johnson B., Teng C.L., Hardee G.E., and Daddona P.E. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm. Res. 18 (2001) 1789-1793
13. Lobie P.E., Garcia-Aragon J., Wang B.S., Baumbach W.R., and Waters M.J. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130 (1992) 3057-3065
14. Martanto W., Davis S.P., Holiday N.R., Wang J., Gill H.S., and Prausnitz M.R. Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21 (2004) 947-952
15. Martanto W., Moore J.S., Couse T., and Prausnitz M.R. Mechanism of fluid infusion during microneedle insertion and retraction. J. Control. Release 112 (2006) 357-361
16. McAllister D.V., Wang P.M., Davis S.P., Park J.H., Canatella P.J., Allen M.G., and Prausnitz M.R. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13755-13760
17. Meidan V.M., and Michniak B.B. Emerging technologies in transdermal therapeutics. Am. J. Ther. 11 (2004) 312-316
18. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 581-587
19. Schuetz Y.B., Naik A., Guy R.H., and Kalia Y.N. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 2 (2005) 533-548
20. Stanimirovic A., Cupic H., Tomas D., Bosnjak B., Balicevic D., Kruslin B., and Belicza M. Immunohistochemical determination of the growth hormone receptor in squamous cell carcinoma of the skin. Acta Dermatoven APA 13 (2004) 3-8
21. Verbaan F.J., Bal S.M., Van den Berg D.J., Groenink W.H.H., Verpoorten H., Luttge R., and Bouwstra J.A. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 117 (2007) 238-245)
22. Widera G., Johnson J., Kim L., Libiran L., Nyam K., Daddona P.E., and Cormier M. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24 (2006) 1653-1664
23. Xie Y., Xu B., and Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomed.: Nanotechnol. Biol. Med. 1 (2005) 184-190